The Valley Desk

NCT03972306 · Interventional trial

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis

Overall registry status Completed

Phase 1

Conditions Multiple Sclerosis (MS)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov